PRNewsWire
02 Oct 2025, 21:52 UTC · 50w ago
Rosen Law Firm Encourages MoonLake Immunotherapeutics Investors to Inquire About Securities Class Action Investigation - MLTX
Verdict
Headline leans bearish. We score MLTX −1.00.
Score confirms the headline.
- Headline says
Leans bearish
From its wording — no explicit rating
- Expected · MLTX
−1.00strongly bearish






